IMpassion130 Data Demonstrate Clinical Benefit for Immunotherapy in Metastatic TNBC
December 18th 2018Leisha A. Emens, MD, PhD, professor of medicine at the UPMC Cancer Center, discusses how the data from the IMpassion130 trial have demonstrated benefit for immunotherapy in metastatic triple-negative breast cancer.